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So far most of the biochemical and structural insight into Roco proteins have come from 
lower organisms and single protein domains. The C. tepidum structure revealed that COR is 
the dimerization device of Roco-proteins and that the Roco-proteins belong to the group of 
GAD proteins. The kinase structure from Roco4 explained the increased activity of the most 
prevalent PD mutation. But several questions remain unanswered. How are the GTPase and 
kinase regulated? Is there cross-talk between these two catalytic domains? What is the 
function of the several protein-protein interaction domains? What are the down- and upstream 
targets of LRRK2? To answer these questions it will be necessary to move away from single 
domains to characterization of full-length proteins. 
 
X-ray crystallography of full-length Roco-proteins will be challenging, since large amounts of 
highly purified protein are needed. In addition it appears that Roco-proteins are quite flexible, 
so they may not crystallize easily. But with cryo-EM it might be more feasible to get a high 
resolution picture of a Roco-protein. Therefore some efforts have been made to elucidate a 
high-resolution cryo-EM structure of LRRK2, but so far they do not have been successful, 
most likely because it is not possible to purify larger amount of highly pure LRRK2. This is 
where one can make use of our Roco4 model again, since it is possible to purify sufficient 
amounts that are necessary for cryo-EM and a more detailed biochemical characterization. 
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